DIFFERENTIAL EXPRESSION OF SUBSTANCE-P RECEPTORS IN PATIENTS WITH CROHNS-DISEASE AND ULCERATIVE-COLITIS

被引:121
作者
MANTYH, CR
VIGNA, SR
BOLLINGER, RR
MANTYH, PW
MAGGIO, JE
PAPPAS, TN
机构
[1] DUKE UNIV,MED CTR,DEPT CELL BIOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
[3] UNIV MINNESOTA,MOLEC NEUROBIOL LAB,MINNEAPOLIS,MN
[4] HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA
关键词
D O I
10.1016/0016-5085(95)90394-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Although clinical and pathological differences exist between Crohn's disease (CD) and ulcerative colitis (UC), distinguishing features are often absent, making diagnosis and treatment problematic. This study evaluated the differences in the expression of substance P (SP) receptors in patients with CD or UC. Methods: Tissue samples from patients with inflammatory bowel disease or control patients were obtained at surgery, processed for I-125-SP binding, and analyzed by quantitative autoradiography. Results: Patients with CD showed a massive increase in SP receptors in lymphoid aggregates, small blood vessels, and enteric neurons of the small and large bowel relative to controls. Six of 16 CD specimens had no pathological evidence of CD yet continued to express high concentrations of SP receptors. Pathologically positive patients with UC showed high concentrations of SP receptors on colonic lymphoid aggregates and small blood vessels but not enteric neurons. No increased SP binding was evident in clinically and pathologically quiescent UC colons and normal UC ileostomy samples. Conclusions: The increased expression of SP receptors on the enteric neurons of patients with CD distinguishes CD from UC. The persistent increased SP binding in pathologically normal CD tissue may indicate a subclinical disease state. SP receptor expression may have important diagnostic, etiologic, and therapeutic usefulness in inflammatory bowel disease.
引用
收藏
页码:850 / 860
页数:11
相关论文
共 60 条
  • [21] LEE KS, 1979, ARCH PATHOL LAB MED, V103, P173
  • [22] INHIBITION OF NEUROGENIC PLASMA EXUDATION IN GUINEA-PIG AIRWAYS BY CP-96,345, A NEW NONPEPTIDE NK(1) RECEPTOR ANTAGONIST
    LEI, YH
    BARNES, PJ
    ROGERS, DF
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (02) : 261 - 262
  • [23] LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282
  • [24] THE NONPEPTIDE TACHYKININ ANTAGONIST, CP-96,345, IS A POTENT INHIBITOR OF NEUROGENIC INFLAMMATION
    LEMBECK, F
    DONNERER, J
    TSUCHIYA, M
    NAGAHISA, A
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (03) : 527 - 530
  • [25] THE 1988 VONEULER,ULF LECTURE - SUBSTANCE-P - FROM EXTRACT TO EXCITEMENT
    LEMBECK, F
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1988, 133 (04): : 435 - 454
  • [26] INTRANEURONAL SUBSTANCE-P CONTRIBUTES TO THE SEVERITY OF EXPERIMENTAL ARTHRITIS
    LEVINE, JD
    CLARK, R
    DEVOR, M
    HELMS, C
    MOSKOWITZ, MA
    BASBAUM, AI
    [J]. SCIENCE, 1984, 226 (4674) : 547 - 549
  • [27] CROHNS DISEASE OF LARGE INTESTINE
    LOCKHART.HE
    MORSON, BC
    [J]. GUT, 1964, 5 (06) : 493 - &
  • [28] EFFECT OF NEUROPEPTIDES ON PRODUCTION OF INFLAMMATORY CYTOKINES BY HUMAN-MONOCYTES
    LOTZ, M
    VAUGHAN, JH
    CARSON, DA
    [J]. SCIENCE, 1988, 241 (4870) : 1218 - 1221
  • [29] THE ROLE OF SUBSTANCE-P AND CALCITONIN GENE-RELATED PEPTIDE IN NEUROGENIC PLASMA EXTRAVASATION AND VASODILATATION IN THE RAT
    LOUIS, SM
    JAMIESON, A
    RUSSELL, NJW
    DOCKRAY, GJ
    [J]. NEUROSCIENCE, 1989, 32 (03) : 581 - 586
  • [30] DISCOVERY OF CP-96,345 AND ITS CHARACTERIZATION IN DISEASE-MODELS INVOLVING SUBSTANCE-P
    LOWE, JA
    DROZDA, SE
    SNIDER, RM
    LONGO, KP
    ZORN, SH
    JACKSON, ER
    MORRONE, J
    MCLEAN, S
    BRYCE, DK
    BORDNER, J
    NAGAHISA, A
    KANAI, Y
    SUGA, O
    TSUCHIYA, M
    [J]. REGULATORY PEPTIDES, 1993, 46 (1-2) : 20 - 23